Funded Tech Companies
Resalis Therapeutics
Resalis Therapeutics, operating out of Turin, received equity investments through private investors, Claris Ventures and Sunstone Life Science Ventures.
Company Overview
Company Name
Resalis Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Via Nizza 52
Turin, 10126
IT
Turin, 10126
IT
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Resalis Therapeutics' transformative metabolic disease approach targets a master regulator of key pathways underlying obesity and fatty liver disease. The company is applying its unique understanding of the non-coding RNA drug modality and lipid metabolism to develop its lead program, RES-010, into a safe and convenient treatment providing disease-modifying therapeutic impact including durable weight loss and reduction of hepatic steatosis.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
1/4/2024
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Alessandro Toniolo
Company Investors
- Claris Ventures
- Sunstone Life Science Ventures (Claus Andersson)
- Italian Angels for Growth
- Club degli Investitori
Browse more funded tech companies:
RES-Q Healthcare | ResApp Health
Share this article
About Our Venture Capital Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs